Kristina Burow

Investing Profile

Sweet spot: $50K Range: $50K–$150M Fund: $635.8M

ARCH Venture Partners thesis

Disruptive Companies Explore our portfolio Great Science Learn about ARCH Amazing Teams Meet our entrepreneurs ⬤ ⬤ ⬤ We’re catalyzing discoveries that prevent, detect, and cure disease. Testimonials Read what our entrepreneurs are saying about ARCH. "...I continually marvel at [ARCH's] deep involvement and commitment." Jay Flatley, Executive Chairman "[ARCH] is committed to building truly transformational companies..." Hans Bishop, Former CEO "There is no other venture firm like ARCH." Ryan Watts, Ph.D., CEO "ARCH is unique in its ability to see the waves before they start to form." David Sche

Sector and stage focus

  • Series A: AgTech, Consumer Health, BioTech, Pharmaceuticals
  • Seed: Pharmaceuticals, AgTech, BioTech, Consumer Health
  • general: Diverse Investors, Female Investors, San Francisco Bay Area

Recent investments by Kristina Burow

Kristina Burow has 4 named past investments in the public record. The most recent:

Company Stage Date Round size
Receptos Series B Mar 2013 $30M
Gossamer Bio Series A Jan 2018 $100M
Vir Biotechnology Venture Round Jan 2017 $150M
Kilimanjaro Energy Series A Aug 2010 $2.3M

Frequent co-investors

Kristina Burow has co-invested with: Richard Lim, Robert Nelsen, Bryan Roberts.

Is Kristina Burow a fit for your round?

Upload your pitch deck and see whether Kristina Burow appears in your top 20 matches.

Find investors for your deck